Nikhil Puri has over 25 years of experience serving the pharmaceutical industry. Nikhil has held senior positions within the pharma industry and as a healthcare investment banker. Mr. Puri currently serves as a Partner and Managing Director at Signet Healthcare Partners, a New York based Private Equity Fund that invests predominantly in pharmaceutical products, pharmaceutical services and medical technology businesses. Prior to joining Signet, Nikhil was responsible for worldwide business development of the Global Established Pharmaceuticals (GEP) business at Pfizer that encompassed the Company’s legacy brands, sterile injectables, generics and biosimilars portfolios.
He served as a member of both Pfizer’s Business Development leadership team and the GEP leadership team and Investment Committee. Prior to joining Pfizer, Nikhil spent 15 years as an investment banker in the United States and in Asia at firms including Lehman Brothers and Bear Stearns, predominantly focused on the pharmaceutical sector. During that time period he was involved in the consummation of over 50 capital raising and strategic advisory transactions with an aggregate value exceeding $20 billion.
Nikhil received his Masters of Business Administration from New York University. He has a bachelor’s degree in commerce from the University of Mumbai and is a member of the Institute of Chartered Accountants of India.